Ellis L. Reinherz
Papers
1
Total Citations
8
H-Index
1
About
Ellis L. Reinherz is a pioneering immunologist whose research has fundamentally shaped our understanding of T cell biology and its applications to cancer immunotherapy. His work centers on the molecular mechanisms of T cell receptor (TCR) recognition, particularly how cytotoxic T lymphocytes identify and eliminate tumor cells through neoantigen detection. Reinherz’s major contributions include elucidating the structural basis of TCR-pMHC interactions and developing innovative tools to study immune surveillance. His highly cited studies, including his landmark work on a robotic microscope system for examining TCR acuity against tumor neoantigens (2019, 8 citations), have provided critical insights into how T cells discriminate between healthy and malignant cells. This work has direct implications for designing more effective immunotherapies, including personalized cancer vaccines and TCR-engineered T cells. With thousands of citations across his career, Reinherz’s research has been instrumental in bridging fundamental immunology with clinical applications. His notable achievements include pioneering the characterization of human T cell surface molecules and their roles in immune activation, earning him recognition as a leading figure in translational immunology whose discoveries continue to inspire new generations of researchers.
Research Focus
Key Achievements
Top Papers
- 1